Macular oedema (diabetic) - ranibizumab (rapid review of TA237): final appraisal determination guidance
|
Macular oedema (diabetic) - ranibizumab (rapid review of TA237): final appraisal determination guidance
04 January 2013 (277.51 Kb 20 sec) |
This page was last updated: 31 December 2012